🇺🇸 FDA
Pipeline program

Trecondi 1 g powder for solution for infusion, FLUDARABINE PHOSPHATE, THIOTEPA, Trecondi 5 g powder for solution for infusion

APHP190648

Phase 2 small_molecule active

Quick answer

Trecondi 1 g powder for solution for infusion, FLUDARABINE PHOSPHATE, THIOTEPA, Trecondi 5 g powder for solution for infusion for Myelofibrosis is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Myelofibrosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials